As of September 30, 2025, Tonix had $190.1 million in cash and cash equivalents, compared with $98.8 million as of December 31, 2024. Net cash used in operations was approximately $60.2 million for ...

Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first ...

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated ...

Magnesium has grown in popularity of late as more is discovered about the wonder supplement. However, you don't need to rely on pills to increase your daily magnesium. Instead, these foods are ...

Cardiologist Dr Yaranov discusses magnesium supplements beneficial for sleep, including magnesium glycinate, L-threonate, and ...

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya™ (cyclobenzaprine HCl ...

“A standout quarter on every front — marked by strong execution, growing demand for our AI-powered solutions, and Advanced AI revenue exceeding $100M this quarter. Our revenue grew 2.4% sequentially ...

† Department of Energy, Environmental and Chemical Engineering, Washington University, St. Louis, Missouri 63130, United States ‡ Department of Chemistry, Washington University, St. Louis, Missouri ...

Institute of Theoretical Chemistry, University of Vienna, Währinger Str. 17, 1090 Vienna, Austria Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both ...